Duopharma Biotech Berhad (KLSE: DPHARMA)

Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	221.16	270.5	157.64	137.98	158.03	120.67
Cash & Short-Term Investments	221.16	270.5	157.64	137.98	158.03	120.67
Cash Growth	63.14%	71.60%	14.25%	-12.69%	30.96%	22.81%
Accounts Receivable	227.46	135.04	131.31	122.42	112.99	111.89
Other Receivables	21.72	26.38	10.84	10.31	22.18	18.9
Receivables	249.18	161.42	142.15	132.72	135.17	130.79
Inventory	226.85	243.07	235.18	222.19	151.27	144
Prepaid Expenses	-	2.08	6.52	1.9	0.67	0.77
Other Current Assets	-	-	-	-	14.56	20.97
Total Current Assets	697.2	677.07	541.49	494.8	459.69	417.21
Property, Plant & Equipment	571.95	582.37	579.92	542.53	441.79	412.25
Long-Term Investments	28.45	36.91	42.15	73.54	112.25	51.84
Other Intangible Assets	37.74	7.65	3.84	4.95	4.66	0.6
Long-Term Deferred Tax Assets	7.32	8.95	13.33	12.7	8.54	9.2
Long-Term Deferred Charges	-	31.15	40.14	34.58	30.41	27.52
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.1	1.2
Total Assets	1,344	1,345	1,222	1,164	1,058	919.8
Accounts Payable	107.06	44.53	51.93	31.32	28.15	34.67
Accrued Expenses	-	33.79	40.46	61.2	45.62	56.6
Short-Term Debt	-	50.59	101.8	87.85	36.11	109.66
Current Portion of Long-Term Debt	51.15	14.95	32.34	15.08	12.68	15
Current Portion of Leases	-	0.92	0.94	0.64	0.6	0.78
Current Income Taxes Payable	2.06	0.37	1.17	6.06	0.74	0.65
Other Current Liabilities	-	21.58	35.95	28.17	26.41	22.08
Total Current Liabilities	160.26	166.73	264.59	230.31	150.32	239.44
Long-Term Debt	472.79	480.9	294.6	297.8	253.28	139.74
Long-Term Leases	1.64	1.48	1.92	2.48	0.66	0.82
Long-Term Deferred Tax Liabilities	15.07	8.91	5.58	9.54	10.35	10.05
Total Liabilities	649.76	658.01	566.7	540.13	414.61	390.05
Common Stock	432.47	432.47	419.37	405.86	404.92	374.4
Retained Earnings	333.72	319.07	288.37	239.97	220.18	182.95
Comprensive Income & Other	-72.23	-64.41	-52.52	-21.82	18.72	-27.6
Shareholders' Equity	693.95	687.12	655.22	624	643.82	529.75
Total Liabilities & Equity	1,344	1,345	1,222	1,164	1,058	919.8
Total Debt	525.57	548.85	431.6	403.84	303.33	266
Net Cash (Debt)	-304.41	-278.35	-273.97	-265.86	-145.31	-145.33
Net Cash Per Share	-0.32	-0.29	-0.29	-0.29	-0.16	-0.16
Filing Date Shares Outstanding	961.94	961.94	952.24	941.77	941.37	912.51
Total Common Shares Outstanding	961.94	961.94	952.24	941.77	941.37	912.51
Working Capital	536.93	510.34	276.9	264.49	309.37	177.76
Book Value Per Share	0.72	0.71	0.69	0.66	0.68	0.58
Tangible Book Value	656.21	679.47	651.38	619.06	639.16	529.16
Tangible Book Value Per Share	0.68	0.71	0.68	0.66	0.68	0.58
Land	-	65.68	69.88	69.88	69.88	69.88
Buildings	-	265.86	125.23	124.51	119.57	58.67
Machinery	-	435.18	368.47	308.94	291.64	269.57
Construction In Progress	-	8.48	172.65	162.63	65.81	93.33

Source: S&P Capital IQ. Standard template. Financial Sources.